Oncology Clinical Development Expertise

Veristat’s experienced teams have helped clients with more than  390 Oncology studies for solid tumors, hematologic malignancies and more.  Additionally, we’ve worked on over 30 US and European regulatory submission projects for cancer treatments, including many rare cancers.

Oncology Experience

With cancer being the second* leading cause of death today, it’s no wonder that Veristat’s clients are prioritizing their pipelines to developing life-saving and life-extending cancer therapies. Nearly half of Veristat’s current clinical development programs are supporting oncology products.

Veristat’s teams work on a spectrum of amazing cancer treatments including drugs, biologics, and diagnostics, such as:

  • Chemo-Therapies
  • Gene Therapies
  • Immuno-Therapies
  • Radiation Therapies
  • Surgical Procedures
  • Transplants
  • Vaccines/Self-Vaccines

*Source: http://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm
veristat_oncologyandcancer_clinicaltrial_expertise.png

Contact Veristat Now

Request A Proposal

Contact Us

Explore The Types of Cancer Trials We've Worked On

Solid Tumor Experience Includes:

  • Bladder
  • Biliary
  • Breast
  • Brain
  • Cervical
  • Colorectal
  • Gastric
  • Lung
  • Non Small Cell Lung (NSCL)
  • Ovarian
  • Pancreatic
  • Prostate
  • Renal Cell
  • Skin
  • Thyroid

Hematologic Malignancy Experience Includes:

  • Acute Myeloid Leukemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Cutaneous T Cell Lymphoma (CTCL)
  • Follicular Lymphoma
  • Mantle Cell Lymphoma
  • Multiple Myeloma
  • Myelofibrosis with Myeloid Metaplasia
  • Myelodysplastic Syndromes/ Anemia
  • Peripheral T Cell Lymphoma (PTCL)
  • Non-Hodgkin’s Lymphoma
  • Waldenstrom's Macroglobulinemia

Learn more about all of our hematology experience including non-malignant blood diseases.

Contact Veristat to Learn More
veristat_candid-5-optimized.jpg

We support our clients’ innovative, life-extending and life-saving cancer treatments that range from cancer vaccines to prolong progression free survival (PFS) to new immuno-therapies for cancers no longer responding to standard treatments to more traditional multi-drug chemotherapy regimens. Our teams’ have the expertise and experiences to help you design, build, and run your oncology/hematology clinical development program. And, we’ll help you navigate the regulatory submission process. Contact us to learn more about our experiences and how we can apply our experience and knowledge to your study.  

Contact Us
Contact Us
Request A Proposal